AI assistant
Sending…
IN8BIO, INC. — Director's Dealing 2022
Aug 18, 2022
35200_dirs_2022-08-18_135b9c0e-3ec7-455e-a0c8-7120a630088f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2022-08-16
Reporting Person: Ho William Tai-Wei (Director, President, CEO and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-16 | Common Stock | P | 26315 | $1.90 | Acquired | 2315745 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 72999 | Indirect |
| Common Stock | 73000 | Indirect |
| Common Stock | 36500 | Indirect |
| Common Stock | 36500 | Indirect |
| Common Stock | 36500 | Indirect |
Footnotes
F1: The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.
More from IN8BIO, INC.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7